The store will not work correctly when cookies are disabled.
2-Cyano-3-(3,4-dihydroxy-phenyl)-acrylic acid 2-(2-methoxy-phenyl)-ethyl ester
ID: ALA37180
PubChem CID: 14840975
Max Phase: Preclinical
Molecular Formula: C19H17NO5
Molecular Weight: 339.35
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccccc1CCOC(=O)/C(C#N)=C/c1ccc(O)c(O)c1
Standard InChI: InChI=1S/C19H17NO5/c1-24-18-5-3-2-4-14(18)8-9-25-19(23)15(12-20)10-13-6-7-16(21)17(22)11-13/h2-7,10-11,21-22H,8-9H2,1H3/b15-10+
Standard InChI Key: WTQFKFWJPRXJSN-XNTDXEJSSA-N
Molfile:
RDKit 2D
25 26 0 0 0 0 0 0 0 0999 V2000
4.5417 -4.3542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8292 -4.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2542 -4.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5417 -3.5292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5417 -2.7042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.3917 -3.1167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1125 -4.3542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6792 -3.5292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1125 -3.5292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9667 -4.3542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8375 -8.0625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8292 -7.2417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6792 -4.3542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2542 -5.5917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.3917 -4.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3917 -2.2917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.9667 -3.1167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.5542 -8.4667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.5417 -6.0042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5417 -6.8292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1292 -8.4792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1167 -6.8292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5542 -9.2917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4042 -7.2417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4042 -8.0667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 1 1 0
4 1 1 0
5 4 3 0
6 9 2 0
7 2 1 0
8 13 2 0
9 7 1 0
10 3 2 0
11 12 1 0
12 20 1 0
13 15 1 0
14 3 1 0
15 7 2 0
16 6 1 0
17 8 1 0
18 11 1 0
19 14 1 0
20 19 1 0
21 11 2 0
22 12 2 0
23 18 1 0
24 22 1 0
25 24 2 0
8 6 1 0
25 21 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 339.35 | Molecular Weight (Monoisotopic): 339.1107 | AlogP: 2.80 | #Rotatable Bonds: 6 |
Polar Surface Area: 99.78 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.41 | CX Basic pKa: ┄ | CX LogP: 3.58 | CX LogD: 3.54 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.36 | Np Likeness Score: -0.07 |
References
1. Cho H, Ueda M, Tamaoka M, Hamaguchi M, Aisaka K, Kiso Y, Inoue T, Ogino R, Tatsuoka T, Ishihara T.. (1991) Novel caffeic acid derivatives: extremely potent inhibitors of 12-lipoxygenase., 34 (4): [PMID:2016727] [10.1021/jm00108a039] |